Financial conflicts of interest in propensity score-matched studies evaluating biologics and biosimilars for inflammatory bowel disease

HIGHLIGHTS

• who: Karam Elsolh et al. from the Michael GDeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada have published the paper: Financial Conflicts of Interest in Propensity Score-Matched Studies Evaluating Biologics and Biosimilars for Inflammatory Bowel Disease, in the Journal: (JOURNAL)
• what: The authors determined the prevalence of FCOI among propensity score-matched studies evaluating IBD biologics and biosimilars, and association of FCOI with positive study outcomes.
• how: The authors conducted a systematic search for PSM studies comparing biologics and biosimilars in IBD treatment. The authors obtained payment data from CMS-OP . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.